K. Anstey, D. Lipnicki, and L. Low, Cholesterol as a Risk Factor for Dementia and Cognitive Decline: A Systematic Review of Prospective Studies With Meta-Analysis, The American Journal of Geriatric Psychiatry, vol.16, issue.5, pp.343-354, 2008.
DOI : 10.1097/01.JGP.0000310778.20870.ae

N. Shepardson, G. Shankar, and D. Selkoe, Cholesterol Level and Statin Use in Alzheimer Disease, Archives of Neurology, vol.68, issue.10, pp.1239-1244, 2011.
DOI : 10.1001/archneurol.2011.203

A. Dupuy, I. Carriere, J. Scali, J. Cristol, K. Ritchie et al., Lipid levels and cardiovascular risk in elderly women: a general population study of the effects of hormonal treatment and lipid-lowering agents Lipids and cardiovascular disease: do the findings and therapy apply equally to men and women?, Karas RH (2005) Molecular and cellular basis of cardiovascular gender differences, pp.74-83, 1992.

D. Polk and T. Naqvi, Cardiovascular disease in women: Sex differences in presentation, risk factors, and evaluation, Current Cardiology Reports, vol.101, issue.Suppl II, pp.166-172, 2005.
DOI : 10.1007/s11886-005-0072-9

S. Artero, M. Ancelin, F. Portet, A. Dupuy, C. Berr et al., Risk profiles for mild cognitive impairment and progression to dementia are gender specific, Journal of Neurology, Neurosurgery & Psychiatry, vol.79, issue.9, pp.979-984, 2008.
DOI : 10.1136/jnnp.2007.136903

URL : https://hal.archives-ouvertes.fr/inserm-00294905

D. Andrade, F. Maluf, S. Schuch, J. Voigt, F. Barros et al., The influence of the S19W SNP of the APOA5 gene on triglyceride levels in southern Brazil: Interactions with the APOE gene, sex and menopause status, Nutrition, Metabolism and Cardiovascular Diseases, vol.21, issue.8, pp.584-590, 2011.
DOI : 10.1016/j.numecd.2009.12.013

A. Sanders, C. Wang, M. Katz, C. Derby, N. Barzilai et al., Association of a Functional Polymorphism in the Cholesteryl Ester Transfer Protein (<emph type="ital">CETP</emph>) Gene With Memory Decline and Incidence of Dementia, JAMA, vol.303, issue.2, pp.150-158, 2010.
DOI : 10.1001/jama.2009.1988

3. The and . Group, Vascular factors and risk of dementia: Design of the three city study and baseline characteristics of the study population, Neuroepidemiology, vol.22, pp.316-325, 2003.

I. Rosow and N. Breslau, A Guttman Health Scale for the Aged, Journal of Gerontology, vol.21, issue.4, pp.556-559, 1966.
DOI : 10.1093/geronj/21.4.556

L. Radloff, The CES-D Scale: A Self-Report Depression Scale for Research in the General Population, Applied Psychological Measurement, vol.1, issue.3, pp.385-401, 1977.
DOI : 10.1177/014662167700100306

J. Empana, M. Zureik, J. Gariepy, D. Courbon, J. Dartigues et al., The Metabolic Syndrome and the Carotid Artery Structure in Noninstitutionalized Elderly Subjects: The Three-City Study, Stroke, vol.38, issue.3, pp.893-899, 2007.
DOI : 10.1161/01.STR.0000257983.62530.75

D. Commenges, L. Letenneur, P. Joly, A. Alioum, and J. Dartigues, Modelling age-specific risk: application to dementia, Statistics in Medicine, vol.17, issue.17, pp.1973-1988, 1998.
DOI : 10.1002/(SICI)1097-0258(19980915)17:17<1973::AID-SIM892>3.0.CO;2-5

M. Ancelin, I. Carrière, P. Barberger-gateau, S. Auriacombe, O. Rouaud et al., press) Lipid Lowering Agents, Cognitive Decline, and Dementia: The Three-City Study, J Alzheimers Dis

Z. Tan, S. Seshadri, A. Beiser, P. Wilson, D. Kiel et al., Plasma Total Cholesterol Level as a Risk Factor for Alzheimer Disease, Archives of Internal Medicine, vol.163, issue.9, pp.1053-1057, 2003.
DOI : 10.1001/archinte.163.9.1053

G. Li, J. Shofer, W. Kukull, E. Peskind, D. Tsuang et al., Serum cholesterol and risk of Alzheimer disease: A community-based cohort study, Neurology, vol.65, issue.7, pp.1045-1050, 2005.
DOI : 10.1212/01.wnl.0000178989.87072.11

J. Moroney, M. Tang, L. Berglund, S. Small, C. Merchant et al., Low-Density Lipoprotein Cholesterol and the Risk of Dementia With Stroke, JAMA, vol.282, issue.3, pp.254-260, 1999.
DOI : 10.1001/jama.282.3.254

C. Reitz, M. Tang, N. Schupf, J. Manly, R. Mayeux et al., Association of Higher Levels of High-Density Lipoprotein Cholesterol in Elderly Individuals and Lower Risk of Late-Onset Alzheimer Disease, Archives of Neurology, vol.67, issue.12, pp.1491-1497, 2010.
DOI : 10.1001/archneurol.2010.297

C. Reitz, M. Tang, N. Schupf, J. Manly, R. Mayeux et al., A Summary Risk Score for the Prediction of Alzheimer Disease in Elderly Persons, Archives of Neurology, vol.67, issue.7, pp.835-841, 2010.
DOI : 10.1001/archneurol.2010.136

C. Reitz, M. Tang, J. Luchsinger, and R. Mayeux, Relation of Plasma Lipids to Alzheimer Disease and Vascular Dementia, Archives of Neurology, vol.61, issue.5, pp.705-714, 2004.
DOI : 10.1001/archneur.61.5.705

S. Kalmijn, D. Foley, L. White, C. Burchfiel, J. Curb et al., Metabolic Cardiovascular Syndrome and Risk of Dementia in Japanese-American Elderly Men : The Honolulu-Asia Aging Study, Arteriosclerosis, Thrombosis, and Vascular Biology, vol.20, issue.10, pp.2255-2260, 2000.
DOI : 10.1161/01.ATV.20.10.2255

R. Stewart, L. White, Q. Xue, and L. Launer, Twenty-six???Year Change in Total Cholesterol Levels and Incident Dementia, Archives of Neurology, vol.64, issue.1, pp.103-107, 2007.
DOI : 10.1001/archneur.64.1.103

M. Mielke, P. Zandi, M. Sjogren, D. Gustafson, S. Ostling et al., High total cholesterol levels in late life associated with a reduced risk of dementia, Neurology, vol.64, issue.10, pp.1689-1695, 2005.
DOI : 10.1212/01.WNL.0000161870.78572.A5

M. Mielke, P. Zandi, H. Shao, M. Waern, S. Ostling et al., The 32-year relationship between cholesterol and dementia from midlife to late life, Neurology, vol.75, issue.21, pp.1888-1895, 2010.
DOI : 10.1212/WNL.0b013e3181feb2bf

M. Kivipelto, E. Helkala, M. Laakso, T. Hanninen, M. Hallikainen et al., Apolipoprotein E ??4 Allele, Elevated Midlife Total Cholesterol Level, and High Midlife Systolic Blood Pressure Are Independent Risk Factors for Late-Life Alzheimer Disease, Annals of Internal Medicine, vol.137, issue.3, pp.149-155, 2002.
DOI : 10.7326/0003-4819-137-3-200208060-00006

A. Solomon, I. Kareholt, T. Ngandu, B. Winblad, A. Nissinen et al., Serum cholesterol changes after midlife and late-life cognition: Twenty-one-year follow-up study, Neurology, vol.68, issue.10, pp.751-756, 2007.
DOI : 10.1212/01.wnl.0000256368.57375.b7

C. Raffaitin, H. Gin, J. Empana, C. Helmer, C. Berr et al., Metabolic Syndrome and Risk for Incident Alzheimer's Disease or Vascular Dementia: The Three-City Study, Diabetes Care, vol.32, issue.1, pp.169-174, 2009.
DOI : 10.2337/dc08-0272

R. Kalaria, G. Maestre, R. Arizaga, R. Friedland, D. Galasko et al., Alzheimer's disease and vascular dementia in developing countries: prevalence, management, and risk factors, The Lancet Neurology, vol.7, issue.9, pp.812-826, 2008.
DOI : 10.1016/S1474-4422(08)70169-8

T. Yoshitake, Y. Kiyohara, I. Kato, T. Ohmura, H. Iwamoto et al., Incidence and risk factors of vascular dementia and Alzheimer's disease in a defined elderly Japanese population: The Hisayama Study, Neurology, vol.45, issue.6, pp.1161-1168, 1995.
DOI : 10.1212/WNL.45.6.1161

L. Middleton and K. Yaffe, Promising Strategies for the Prevention of Dementia, Archives of Neurology, vol.66, issue.10, pp.1210-1215, 2009.
DOI : 10.1001/archneurol.2009.201

P. Barter, A. Gotto, J. Larosa, J. Maroni, M. Szarek et al., HDL Cholesterol, Very Low Levels of LDL Cholesterol, and Cardiovascular Events, New England Journal of Medicine, vol.357, issue.13, pp.1301-1310, 2007.
DOI : 10.1056/NEJMoa064278

T. Sampietro, F. Bigazzi, D. Pino, B. Puntoni, M. Bionda et al., HDL: The ???new??? target of cardiovascular medicine, International Journal of Cardiology, vol.108, issue.2, pp.143-154, 2006.
DOI : 10.1016/j.ijcard.2005.04.036

S. Patel, R. Puranik, S. Nakhla, P. Lundman, R. Stocker et al., Acute hypertriglyceridaemia in humans increases the triglyceride content and decreases the anti-inflammatory capacity of high density lipoproteins, Atherosclerosis, vol.204, issue.2, pp.424-428, 2009.
DOI : 10.1016/j.atherosclerosis.2008.07.047

M. Michikawa, Cholesterol paradox: Is high total or low HDL cholesterol level a risk for Alzheimer's disease?, Journal of Neuroscience Research, vol.72, issue.2, pp.141-146, 2003.
DOI : 10.1002/jnr.10585

H. Wolf, A. Hensel, T. Arendt, M. Kivipelto, B. Winblad et al., Serum lipids and hippocampal volume: the link to Alzheimer's disease? Ann Neurol, pp.745-748, 2004.

M. Pappolla, T. Bryant-thomas, D. Herbert, J. Pacheco, F. Garcia et al., Mild hypercholesterolemia is an early risk factor for the development of Alzheimer amyloid pathology, Neurology, vol.61, issue.2, pp.199-205, 2003.
DOI : 10.1212/01.WNL.0000070182.02537.84

L. Weiss, L. Pan, M. Abney, and C. Ober, The sex-specific genetic architecture of quantitative traits in humans, Nature Genetics, vol.12, issue.2, pp.218-222, 2006.
DOI : 10.1038/ng1726

M. Ancelin and K. Ritchie, Lifelong Endocrine Fluctuations and Related Cognitive Disorders, Current Pharmaceutical Design, vol.11, issue.32, pp.4229-4252, 2005.
DOI : 10.2174/138161205774913228

URL : https://hal.archives-ouvertes.fr/inserm-00243083

M. Sowers, J. Symons, M. Jannausch, J. Chu, and S. Kardia, Sex Steroid Hormone Polymorphisms, High-Density Lipoprotein Cholesterol, and Apolipoprotein A-1 from the Study of Women???s Health Across the Nation (SWAN), The American Journal of Medicine, vol.119, issue.9, pp.61-68, 2006.
DOI : 10.1016/j.amjmed.2006.07.008

E. Sundermann, P. Maki, and J. Bishop, A review of estrogen receptor ?? gene (ESR1) polymorphisms, mood, and cognition, Menopause, vol.17, issue.4, pp.874-886, 2010.
DOI : 10.1097/gme.0b013e3181df4a19